

a VINNOVA-funded innovation initiative

NEWS
Theranostics Trial Alliance Sweden, TTA Sweden: National Strategy – Positioning Sweden at the Forefront of Radiotheranostics Clinical Research

06-11-2026, 12.15 – 16.15
H1 Röd Room, Alfred Nobels allé 23, 141 52 Huddinge,
Sweden
Target audience
Researchers, clinicians, healthcare leaders, policymakers, regulatory authorities, life science companies, patient representatives and other stakeholders involved in radiopharmaceutical development and clinical trials.
Purpose
The TTA Sweden Annual Symposium will explore how Sweden comes together to strengthen its capacity to conduct clinical trials with radiopharmaceuticals and become a more attractive partner for national and international study sponsors.
The symposium will bring together leading national and international experts in onco-theranostics and will highlight new developments, opportunities and practical solutions for expanding clinical-trial capacity, strengthening national coordination, accelerating radiopharmaceutical manufacturing and study start-up, improving patient recruitment, and facilitating multicentre trials. It will also showcase current initiatives and capabilities within TTA Sweden.
See the program below.
The symposium is free of charge. Register to secure your attendance.
Preliminary Symposium Program
12.00 – 12.30 Coffee and registration
12.30 – 12.35 Welcome by Prof Fredrik Frejd and Associate prof Thuy Tran
12.35 – 13.05 Invited keynote speaker Prof Willemien Menke-van der Houven van Oort, Amsterdam UMC
PET imaging in oncology for drug development and as a tool for patient selection and treatment evaluation
13.05 – 13.15 Dr. Sara Strandberg, PhD, Associate prof, Umeå University Hosptial, Umeå University
Title: TBD
13.15 – 13.45 Coffee break
13.45 – 13.55 Prof Mark Lubberink, Uppsala University
Title: TBD
14.00 – 14.30 Keynote speaker to be confirmed
14.30 – 15.00 Panel discussion: Sponsor perspectives on accelerating radiopharmaceutical clinical development
Key stakeholders and priorities
15.00 – 15.15 Short break
15.15 – 15.45 Tribute session honouring Professor Rimma Axelsson
Chair: prof Håkan Geijer
15.50 – 16.00 Closing remarks
Prof Rimma Axelsson
Study protocol article Her2-Ex PET trial published in Frontiers in Oncology, April 10, 2026.
Read the full article here

Webbinar: health economics May 4, 2026
The webinar will be held in Swedish and will take place via Teams from 15:00-16.30.
Teams link: https://teams.microsoft.com/meet/34046749700331?p=wkZOKEMYLypcSIWDRY
Mötes-ID: 340 467 497 003 31
Lösenord: JM9sH6Dd
